Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once‐daily Versus Multiple‐daily Dosing With Intravenous Aminoglycosides for Cystic Fibrosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/images/google-play-badge.png. Accessed 07 May 2024.
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/images/google-play-badge.png. Accessed May 7, 2024.
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/images/google-play-badge.png
Once‐daily Versus Multiple‐daily Dosing With Intravenous Aminoglycosides for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. [cited 2024 May 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis
ID - 434322
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -